Delivery Order SPE2DB22D2211-SPE2DB25FSDRJ
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,031.84 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is an antiarrhythmic medication used in the treatment of atrial fibrillation,...
- The Defense Logistics Agency awarded a $1,890.09 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract type. The award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used in the management...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count) valued at $6,160.39 under a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. MULTAQ is a prescription antiarrhythmic medication used to reduce the risk...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,736.64 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $11,535.63 to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg on August 25, 2025, with a completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used in the treatment of atrial fibrillation and represents one...
- The Defense Logistics Agency awarded a delivery order valued at $1,865.37 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-unit quantity), with performance in Conshohocken, Pennsylvania and completion by September 2, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. MULTAQ is an antiarrhythmic...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) with a ceiling value of $20,309.79. The contract, awarded on September 3, 2025, utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025. This award represents a non-set-aside competitive procurement and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. MULTAQ is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $5,234.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-unit package). This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the management of atrial fibrillation, representing a...